{"id":225274,"date":"2026-02-24T12:11:18","date_gmt":"2026-02-24T09:11:18","guid":{"rendered":"https:\/\/new-inbit.dev-praxis.gr\/?post_type=hta_library&#038;p=225274"},"modified":"2026-02-24T12:11:21","modified_gmt":"2026-02-24T09:11:21","slug":"health-technology-assessment-of-medical-devices-a-survey-of-non-european-union-agencies","status":"publish","type":"hta_library","link":"https:\/\/www.inbit.gr\/el\/hta_library\/health-technology-assessment-of-medical-devices-a-survey-of-non-european-union-agencies\/","title":{"rendered":"Health Technology Assessment of Medical Devices: A Survey of non-European Union Agencies"},"content":{"rendered":"\n<p>Objectives: The aim of this study was to review and compare current health technology assessment (HTA) activities for medical devices across non-European Union HTA agencies.<\/p>\n\n\n\n<p>Methods: HTA activities for medical devices were evaluated from three perspectives: organizational structure, processes, and methods. Agencies were primarily selected upon&nbsp;membership of existing HTA networks. The data collection was performed in two stages: stage 1\u2013agency Web-site assessment using a standardized questionnaire, followed by&nbsp;review and validation of the collected data by a representative of the agency; and stage 2\u2013semi-structured telephone interviews with key informants of a sub-sample of agencies.<\/p>\n\n\n\n<p>Results: In total, thirty-six HTA agencies across twenty non-EU countries assessing medical devices were included. Twenty-seven of thirty-six (75 percent) agencies were judged at&nbsp;stage 1 to have adopted HTA-specific approaches for medical devices (MD-specific agencies) that were largely organizational or procedural. There appeared to be few differences in&nbsp;the organization, process and methods between MD-specific and non\u2013MD-specific agencies. Although the majority (69 percent) of both categories of agency had specific methods&nbsp;guidance or policy for evidence submission, only one MD-specific agency had developed methodological guidelines specific to medical devices. In stage 2, many MD-specific agencies&nbsp;cited insufficient resources (budget, skilled employees), lack of coordination (between regulator and reimbursement bodies), and the inability to generalize findings from evidence&nbsp;synthesis to be key challenges in the HTA of medical devices.<\/p>\n\n\n\n<p>Conclusions: The lack of evidence for differentiation in scientific methods for HTA of devices raises the question of whether HTA needs to develop new methods for medical devices&nbsp;but rather adapt existing methodological approaches. In contrast, organizational and\/or procedural adaptation of existing HTA agency frameworks to accommodate medical devices&nbsp;appear relatively commonplace.<\/p>\n","protected":false},"featured_media":0,"template":"","categories":[21],"tags":[],"class_list":["post-225274","hta_library","type-hta_library","status-publish","hentry","category-review-papers"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/hta_library\/225274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/hta_library"}],"about":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/types\/hta_library"}],"wp:attachment":[{"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/media?parent=225274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/categories?post=225274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inbit.gr\/el\/wp-json\/wp\/v2\/tags?post=225274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}